Board Candidates – Deep Data Dive

Browse the board candidates below. You can sort each column and real-time search by specialty, expertise, etc.

LastFirstDegInstitutionTitleRankSpecialtyAreas of ExpertiseContactStatement
AndersonAnaPhDBHAssociate Scientist, NeurologyAssociate ProfessorNeurologyAutoimmunity
Clinical Translation
Make an IntroI am currently the Albert H Coons Associate Professor of Neurology in the
Field of Immunologic diseases. I am an Immunologist with expertise in
autoimmune disease and cancer. I am inventor on multiple patents some of
which have formed the basis for start-up companies. I have been fortunate
to serve on multiple scientific advisory boards for startup biotech companies
in the immune-oncology space and see the development of therapeutics go
all the way into clinical trials. I am passionate about how the power of the
immune system is being harnessed to make a difference in patient’s lives and
how high throughput technologies have accelerated biological discovery.
AndersonShellyBHEVP and Chief Operating OfficerOperationsHealthcare Administration
Healthcare Delivery
Employee and Patient Experience
Make an IntroMy career passion is and has always been about improving health and the
delivery of health care – making real progress through innovation, clinical
integration, and operational excellence for the next generation of patients
and communities – wherever they might be, clinical teams, innovators, and
BasgozNesliMDMGHAssociate Chief, Infectious DiseaseAssociate ProfessorInfectious DiseaseMake an Intro
BertagnolliMonicaMDBHAssociate SurgeonProfessorSurgical OncologySurgical Oncology
Clinical Trials
Health Information Technology
Make an Intro
Borg-SteinJoanneMDNWHChief, Physical Medicine and RehabilitationAssociate ProfessorPhysical Medicine and RehabilitationRegernative Sports Medicine
Osteoarthritis and Musculoskeletal Disorders
Make an IntroOrthobiologic / regenerative medicine treatments for sports injuries and
osteoarthritis. These include: platelet rich plasma and cell therapies: bone
marrow aspirate concentrate and micronized fat transfer among others.
Neurological Disorders
Gene-based Therapies
Make an IntroI am a PhD Geneticist at MGH and Professor of Neurology at HMS. I am
particularly interested in gene therapy for neurologic diseases and am very
excited about our new extracellular vesicle (exosome) delivery system which
provides biologic vehicles for simultaneous and short term delivery of protein,
RNA and DNA which should be ideal for gene editing in vivo.
BredellaMiriamMDMGHDirector, Musculoskeletal Research; Director, Center for Faculty DevelopmentProfessorRadiologyRadiology
Clinical Translation
Faculty Development
Advancement of Women
Make an IntroI am passionate about my clinical work as an interventional musculoskeletal
radiologist at MGH and my research. As a clinical translational NIH-funded
investigator, I focus on using novel functional imaging techniques to
determine the role of different fat depots on bone health and cardiometabolic
risk across the weight spectrum – from anorexia nervosa to severe obesity.
I serve on NIH steering committees and chair working groups on workforce
development and well-being.
I am very passionate about mentoring and faculty development and direct the
MGH Center for Faculty Development where I focus on supporting women
and faculty underrepresented in medicine. At Harvard Catalyst, I direct the
NIH-funded KL2/CMeRIT program where I oversee and mentor the careers
of clinical translational researchers from all Harvard affiliated Hospitals and
specialties. A new passion of mine is leadership and I just started an executive
MBA at MIT/Sloan.
BrittonO'NeilMDMGBSenior VP, Operations and Associate Chief Operating OfficerInstructorOperationsClinical Operations
Medical Education and Training
Health Information Technology
Make an Intro
ColsonYolondaMDMGHChief, Divison of Thoracic SurgeryProfessorThoracic SurgeryLung Cancer
Localized Drug Delivery
Healthcare Delivery
Make an Intro
CudkowiczMeritMDMGHChief, Neurology; Director, Sean M. Healy and AMG Center for ALSProfessorNeurologyNeurological Disorders
Clinical Trials
Make an IntroAs an clinical expert in amyotrophic lateral sclerosis, I am interested in
approaches to accelerate therapy development in all neurodegenerative
disorders. I launched the first platform trial in ALS and the first gene therapy
for familial ALS. My passion is in early phase clinical trial design and conduct.
As co-founder of the Northeast ALS Consortium and Principal Investigator of
the NIH supporter NeuroNEXT phase 2 network for neurological disorders, my
expertise is in forming collaborative initiatives to more rapidly bring findings
from the laboratory to testing in people.
CurryWilliamMDMGHDirector, Neurosurgical OncologyProfessorNeurosurgical OncologyNeurosurgery
Cell Therapy
Healthcare Delivery
Make an IntroI am the Director of Neurosurgical Oncology at Mass General, and I am excited
about cellular immunotherapy opportunities for patients with brain tumors.
Furthermore, advances in translational neuroscience and neurotechnology
will change the ability for patients to recovery from brain injury, including after
surgery or adjuvant therapy for brain cancer.
DavisIrenePhDSRHFounding Director, Spaulding National Running CenterProfessorPhysical Medicine and RehabilitationMusculoskeletal Injuries
Biomechanics and Gait Retraining
Wearable Sensors
Make an IntroI am a Professor in the Department of Physical Medicine and Rehabilitation
and founding Director of the Spaulding National Running Center (SNRC). SNRC
is an integrated clinical and research center aimed at the understanding
the etiology and optimal treatment of musculoskeletal injuries (MSKI) in
active individuals. I am passionate about movement and the importance of
physical activity for overall health. My research focus is biomechanics and
I am interested in optimizing movement patterns to minimize MSKI. Most
biomechanics research has taken place in laboratories and I am most excited
about taking this research outside. With the advent of wearable sensors, we
now have the potential to measure, record and provide FB to individuals during
physical activity in their natural environments. My research team has begun to
use marker less motion capture and machine learning to measure and analyze
these data.
EisenJaneMDMcLeanClinical Director, Center of Excellence in Depression and Anxiety DisordersProfessorPsychiatryNeuroscience
Anxiety Disorders
Obsessive-Compulsive Disorder
Make an Intro
GaribyanLilitMD, PhDMGHPhysician-Scientist, Wellman Center for PhotomedicineAssistant ProfessorDermatologyPain
Technology Development
Clinician-led Innovation
Innovation Education
Make an IntroI am a physician-scientist at Wellman Center for Photomedicine and
assistant Professor in Dermatology at Harvard Medical School. I co-invented,
developed and pioneered the use of injectable ice-slurry device as a new
way of cooling tissue for therapeutic use. I am leading the development of
ice-slurry as a new method of fat removal from the tongue, for treatment of
obstructive sleep apnea. My work also showed that a single injection of ice
slurry around a peripheral nerve reduces physiologic pain sensation for up to
2 months. We are developing this to be a long-lasting opioid free treatment
for peripheral nerve pain following surgery. I am the co-founder of a biotech
company launched in 2019 to commercialize this new technology. I am
passionate about problem-based innovation that has direct impact on patient
care. I love helping other physician identify, deeply understand, and solve
problems through innovation. I co-founded and direct a global initiative (www. ) that is doing that.
GolbyAlexandraMDBHDirector, Image-Guided NeurosurgeryProfessorNeurosurgeryNeurosurgery
Brain Mapping
Image-guided Interventions
Make an IntroI am a professor of Neurosurgery and of radiology at HMS working as a
clinician scientist at Brigham and Women’s Hospital. My work centers on the
use of advanced imaging and image guidance to inform pre-surgical planning
and surgical decision-making for patients undergoing brain surgery. We
also work with novel approaches such as laser interstitial thermal ablation
and focused ultrasound for blood brain barrier opening. I am driven by the
goal of helping patients dealing with very difficult and often life altering
diagnoses and the surgeons and clinicians taking care of those patients. An
area of innovation which I am particularly interested in is developing low cost
solutions which implement complex technology so that more patients and the
doctors caring for them can benefit from advances in imaging.
GreenfieldShellyMDMcLeanChief Academic Officer, Divison of Women's Mental HealthProfessorPsychiatrySubstance Use Disorders
Mental Health
Women’s Health
Health Care Services Delivery for Addiction and Mental Health Disorders
Addiction/Mental Health Behavioral and Pharmacotherapy Treatments
Global Health
Health Disparities
Faculty Development
Digital Health
Make an Intro
GrekaAnnaMD, PhDBHAssociate Physician, Renal DivisionAssociate ProfessorGenes and Disease
Rare Disease
Metabollic Disease
Age-related Disease
Make an Intro
Haas-KoganDaphneMDBHChair, Department of Radiation OncologyProfessorRadiation OncologyRadiation Oncology
Pediatric Oncology
Novel Targeted Cancer Therapies
Make an Intro
HendersonGalenMDBHDirector, Neurocritical Care and Neuroscience Intensive Care UnitAssistant ProfessorNeurologyClinical Trials
Global Health
Critical Care
Make an Intro
InderTerrieMDBHChair, Department of Pediatric Newborn MedicineProfessorNewborn MedicinePediatric and Neonatal ICU
Brain Injury
Technology Optimization
Make an IntroArea of innovation: New technologies and therapies in the intensive care unit
to reduce stress and anxiety in critical care settings to improve outcomes.
Neuroprotective therapies, including stem cell and neuroimmunology novel
therapies to reduce brain injury and enhance neural regeneration following
brain injury.
IyasereChristianaMDMGHDirector, Department of Medicine InnovationAssistant ProfessorMedicine Digital Health
Clinical Translation
Make an Intro
JoffeHadineMDBHVice Chair, Psychiatry Research; Executive Director, Mary Horrigan Connors Center for Women's Health and Gender BiologyProfessorPsychiatryMenopause
Breast Cancer
Women's Health
Make an IntroNovel pharmacotherapies for treatment of neuropsychological symptoms (hot
flashes, insomnia, depression, fatigue) in health women during midlife and in
those undergoing anti-estrogen therapies for breast cancer.
Therapeutic strategies involving drugs, devices, and digital innovations for
diseases that affect women and men that can be advanced through the
inclusion of female-specific and sex/gender-differentiating knowledge.
Johnson-AkejuOluwaseunMDMGHAnesthetist-in-ChiefAssociate ProfessorAnesthesiaAnesthesia
Make an Intro
KellyHillaryMDMGHDirector, Head and Neck ImagingAssistant ProfessorRadiologyRadiology
Head and Neck Cancer
Make an IntroI am a Neuroradiologist specializing in Head and Neck Imaging, with clinical
appointments at both Massachusetts General Hospital and Massachusetts
Eye and Ear. I have particular clinical and research interests in innovation
in CT and MR imaging for evaluation of head and neck cancer and thyroid
and parathyroid disease, and have lectured nationally and internationally on
these topics. I am interested in and passionate about innovation not only in
diagnostic imaging, but also in image-guided therapeutics in the head and
LeeJeannieMD, PhDMGHProfessor, GeneticsProfessorGenetics
X-linked Disorders
Rett Syndrome
Fragile X
RNA Therapeutics
X Reactivation
Noncoding RNA
Make an Intro
LoganMerrandaMD, MPHMGBAssociate Chief Academic OfficerFacultyNephrologyHealthcare Equity, Quality and Safety
Healthcare Administration
Research Management
Internal Medicine
End Stage Renal Disease
Make an Intro
MadrasBerthaPhDMcLeanDirector, Laboratory of Addiction NeurobiologyProfessorNeurobiologyNeuroimaging
Neurobiology and Addiction
Public Policy
Make an Intro
MausMarcelaMD, PhDMGHDirector, Cellular Immunotherapy Cancer CenterAssociate ProfessorImmuno-OncologyImmuno-Oncology
Cell Therapy
Make an IntroI am an oncologist and immunologist, and the Director of the Cellular
Immunotherapy program in the Cancer Center at Mass General. We develop
novel forms of gene-modified immune cells, particularly T cells, to direct
them to cancer. My 3 passions are immunology, gene therapy, and developing
transformative cancer therapies. What excites me the most is to bring new ideas
and immunotherapies into the clinic in a phase I trial, and to complete the bench
to bedside and back to bench circle. In the field of gene and cell therapy, the entire
circle can be completed in the hospital, but of course, to go beyond Phase I and
change the standard of care, industry involvement and scale are critical.
I do serve on several Scientific Advisory Boards and Data Safety Monitoring Boards
for companies developing cell and gene therapies, for cancer indications as well
as other diseases like autoimmunity. I also serve on one board of directors, with a
biotech company working on antibody-based immunotherapy for cancer. One of
my near-term goals is to found a new company, and eventually become a “serial
What I can contribute to a board is domain expertise in clinical, scientific, and
regulatory processes for development of immunotherapies.
Some of the things I want to learn are what makes a successful company, decisionmaking
processes at higher levels, organizational structures, and developing
complex therapies beyond Phase I and the academic setting. My main questions
are about how to choose which opportunities to take and which to decline, and
how to approach and manage potential conflicts of interest in a transparent and
unambiguous way.
McDonnellMarieMDBHChief, Diabetes Section and Director, Diabetes ProgramLecturerDiabetesDiabetes
Blood Glucose Management
Islet Cell Replacement Therapy
Medical Education and Training
Make an Intro
MillerJoanMDMEEChief of OphthalmologyProfessorOphthalmologyInnovation
Clinical Translation
Retinal Disease
Age-related Macular Degeneration
Make an Introam currently Chief of Ophthalmology at Mass Eye and Ear and Mass General
Hospital and Ophthalmologist-in-Chief at Brigham and Women’s Hospital, as
well as Chair of the Harvard Ophthalmology department. In my Chief role I am
responsible for the clinical, research, and education programs of Mass Eye and
Ear, with significant hospital administration including financial oversight, recruiting,
and compliance. As a member of the Mass Eye and Ear Board of Directors, I help
develop and lead the institutional strategy. I am a retina specialist by training, and
was a key team member in the development of the first two therapies for agerelated
macular degeneration (AMD), the most common blinding eye disease in
people over age 50. My work included animal studies, design of clinical trials, the
regulatory process, and introduction of new therapies to clinicians.
I am interested in serving on corporate boards because I want to participate
in drug and device development from the business perspective. I believe my
administrative and clinical knowledge, as well as my leadership experience, will
allow me to contribute in a meaningful way. My current research includes the
study of genomics, metabolomics and imaging biomarkers in retinal disease, as
well as neuroprotection strategies in retinal disease. In addition, in overseeing the
ophthalmology research portfolio I have gained broad exposure to gene-based
therapies. I have served on a number of Scientific Advisory Boards, and served as
an Independent Director on the Alcon Board of Directors. In addition to the Mass
Eye and Ear Board, my volunteer board service includes foundation and advocacy
NourNawalMDBHChair, Department of Obstetrics and GynecologyProfessorObstetrics and GynecologyGlobal Women’s Health
Obstetric Care
Maternal Mortality
Healthcare Equity, Quality and Safety
Make an Intro
PeabodyLauraMGBChief Legal Officer and General CounselGeneral CounselHealth Law
Corporate Governance
Health Insurance
Make an Intro
Pinder-AmakerStephaniePhDMcLeanProgram Director, College Mental Health Program and Chief Diversity, Equity, and Inclusion OfficerAssistant ProfessorPsychologyCollege Mental Health
Healthcare Equity, Quality and Safety
Culturally Responsive Healthcare
Make an IntroI have served as McLean Hospital’s founding director of the College Mental
Health Program (CMHP) since 2008 and became McLean’s first Chief
Diversity, Equity & Inclusion Officer in 2020. The CMHP is a unique and
innovative, data-driven initiative through which we provide clinical services to
students and families, consult to institutions of higher education (IHEs), and
conduct research for promoting college student mental health and wellness.
Annually, students participate in McLean programs from over 200 IHEs--a
demographic unique to our hospital. When consulting to IHEs we design
workshops, trainings, and psychoeducational interventions on a broad range
of topics. Since 2015, however, the top consultation request we have received
from colleges, secondary schools and non-profits is this, “Can you help us to
address the needs of our increasingly diverse student body?” For the CMHP,
we have proactively focused on the needs of diverse, underrepresented and
potentially marginalized students. So, we love answering this question and we
are passionate about providing tools and resources that help schools answer
this question more effectively. Just before the pandemic, we designed a new
model, the Wellness Initiative for Student Equity (WISE), for helping schools to
address the mental health needs of all students more effectively. The model
is scalable such that, when launched, we will be able to reach many more
schools and students than we have been able to work with previously. Given
the longstanding mental health disparities which have been magnified in the
past year, the need to develop WISE campuses will be even greater than ever.
SalimAliMDBHChief, Division of Trauma, Burns, Surgical Critical Care
and Emergency General Surgery
ProfessorTrauma, Burns and Critical CareEmergency General Surgery
Trauma Surgery
Surgical Critical Care
Make an Introam the chief of Trauma, Burns, and surgical intensive
care at the Brigham. For those non -physicians – my patient population is
mostly the result of some sort of unexpected traumatic events, - car accidents,
falls, assaults and interpersonal violence. In terms of an area of innovation
that is exciting to me: One of the things the trauma community has not done
well is understanding the long term effects and outcomes following injury.
Trauma centers have not been equipped to really follow what happens to their
patients once they are discharged. We have put in place a process to follow
patients for up to a year after injury – but this process involves calling patients
and asking a number of validated questions that can be time consuming and
resource intensive. We recently starting looking at using smartphone based
digital phenotyping to passively collect some of this data. Utilizing a smart
phone app that is designed to collect data from smartphone sensors and
usage logs. For example GPS data that can assess community integration:
accelerometer activity to assess physical activity, anonymized phone call and
text message logs to assess for social participation. We don’t know if it will
work but it does, it would greatly enhance our ability to collect some long term
outcomes in our patients.
SequistTomMDMGBChief Patient Experience and Equity OfficerProfessorPatient Experience
Healthcare Equity, Quality and Safety
Make an IntroDr. Sequist is the Mass General Brigham Chief Patient Experience and Equity
Officer, and in this role oversees quality, safety, patient experience, equity, and
community health; as well as medical affairs functions including pharmacy
and clinical credentialing.
I have significant experience in designing new systems to improve care via
health information technology and digital programs, patient engagement, and
provider incentives; all informed by innovative data analytics.
I am passionate about health care equity and the potential for implementing
entirely new solutions to solve issues around access to digital care,
community-based and mobile care, language barriers, and addressing
upstream challenges such as food and housing insecurity.
SheehanRoseMGBChief Human Resources OfficerHuman ResourcesHuman Resources
Make an IntroBabson College.
My field is Human Resources, where I oversee all aspects of our MGB people
practices from talent acquisition, workforce planning, total rewards, employee
engagement, DEI, Occupational Health Services, EAP, executive total rewards.
My passion is leadership. I believe that good leaders drive engagement, create
an inclusive work environment where employees can thrive and build their
If I could drive innovation in any one area, it would be in wellness and mental
health. I would focus on technology that could allow us to scale access to
BH programs, care providers and groups to support employees and their
dependents who are dealing with any mental health issue. This would also
support provider burnout.
ShenoyEricaMD, PhDMGHAssociate Chief, Infection Control UnitAssistant ProfessorInfectious DiseaseInfectious Diseases
Emerging Infections
Clinical Decision Support
Healthcare Economics
Make an IntroUsing innovative technologies and methods that leverage the electronic health
record to improve patient care and healthcare operations.
SilverJulieMDSRHAssociate Chair and Director of Cancer RehabilitationAssociate ProfessorPhysical Medicine and RehabilitationHealth Disparities
Advancement of Women
Science Communication
Make an Intro
SlaugenhauptSusanPhDMGHScientific Director, Mass General Research InstituteProfessorNeurologyGenes and Disease
Research Management
Science Communication
Make an Intro
SloanDebMGBVP, TreasuryFinanceFinancial Analysis
Finance Operations
Advanced Financial Management
Make an IntroAs VP, Treasury, a position which I have held since 2013, I am responsible
for ensuring that Mass General Brigham has adequate capital and liquidity to
achieve its strategic, financial and operational targets. I also oversee capital
markets activities, investor & bank relationships, cash management, insurance
risk financing programs and overall balance sheet risk management. In sum, my
focus is largely to manage, maintain and promote the financial stability of our
organization, reporting to the Chief Financial Officer.
An area of innovation about which I am most passionate is the implementation of
private debt placements within the non-profit healthcare sector. In more simple
terms, non-profit borrowers, such as MGB, typically raise capital via the public debt
markets, relying on investment banks to structure and underwrite their financing
transactions. As part of this process, banks help to identify and market the bonds
to investors. They receive a negotiated fee for each bond sold. By shifting to a
private placement model, I have eliminated the role of the investment bank and
its associated fees, resulting in significant savings, while also reducing the time to
complete a transaction from roughly 6 months to roughly 6 weeks. By leveraging
relationships which I have cultivated with a select group of prominent institutional
investors over many years, I have been able to establish a de facto MGB lender
group to participate in a series of private placements, beginning in 2012, and
aggregating to a cumulative total of $1.5 billion, which is approximately 25% of
MGB’s total debt, resulting in over $45 million in value to MGB. This innovation
in raising capital in the non-profit healthcare sector has since been replicated by
numerous other healthcare borrowers.
SmithBarbaraMD, PhDMGHDirector, Breast Program and Co-Director of the Women's Cancer ProgramAssociate ProfessorSurgical OncologySurgical Oncology
Breast Cancer
Image-guided Interventions
Make an Intro
WiggsJaneyMD, PhDMEEAssociate Chief, Ophthalmology Clinical
ProfessorOpthalmologyGenes and Disease
Ocular Disorders
Genetic Testing
Gene-based Therapies
Make an IntroI am the Associate Chief for clinical Research in Ophthalmology at the Mass
Eye and Ear and the Vice Chair for Clinical Research in Ophthalmology at
Harvard Medical School. I am also the director of the CLIA-certified genetic
testing laboratory for inherited eye diseases and a co-director of the Ocular
Genomics Institute at Mass Eye and Ear. I am a clinician scientist and see
patients in the glaucoma service at MEE. My research is focused on the
genetics of glaucoma and I have received NIH funding for this work for
nearly 30 years. I am absolutely passionate about the translation of genetic
information to clinical practice specifically using genetic risk variants to
identify patients with high disease risk as well as develop novel gene-based
therapies targeting disease-related genes.